P16 Mediated Suppression Of Telomerase In Normal And Malignant Human Breast Cells.

Fiche du document

Type de document
Périmètre
Langue
Relations

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1111/j.1474-9726.2010.00599.x

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/20569236

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1474-9726[electronic], 1474-9718[linking]

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_BF17B87FFFFA2

Licences

info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer


Sujets proches En

Expressive behavior Breasts

Citer ce document

A.V. Bazarov et al., « P16 Mediated Suppression Of Telomerase In Normal And Malignant Human Breast Cells. », Serveur académique Lausannois, ID : 10.1111/j.1474-9726.2010.00599.x


Métriques


Partage / Export

Résumé 0

Summary The cyclin-dependent kinase inhibitor p16(INK4a) (CDKN2A) is an important tumor-suppressor gene frequently inactivated in human tumors. p16 suppresses the development of cancer by triggering an irreversible arrest of cell proliferation termed cellular senescence. Here, we describe another anti-oncogenic function of p16 in addition to its ability to halt cell cycle progression. We show that transient expression of p16 stably represses the hTERT gene, encoding the catalytic subunit of telomerase, in both normal and malignant breast epithelial cells. Short-term p16 expression increases the amount of histone H3 trimethylated on lysine 27 (H3K27) bound to the hTERT promoter, resulting in transcriptional silencing, likely mediated by polycomb complexes. Our results indicate that transient p16 exposure may prevent malignant progression in dividing cells by irreversible repression of genes, such as hTERT, whose activity is necessary for extensive self-renewal.

document thumbnail

Par les mêmes auteurs

Sur les mêmes sujets

Exporter en